Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are receiving prenatal care through UCLA Health
- People who are planning to give birth at UCLA Ronald Reagan or UCLA Santa Monica hospital
- People who have been diagnosed with gestational diabetes (diabetes that develops during pregnancy) using the standard two-step testing process
- People who are 18 years of age or older at the time of the trial
Who may not be able to join:
- People who had diabetes (either Type 1 or Type 2) before becoming pregnant
- People who are pregnant with more than one baby (such as twins or triplets)
- People who have a uterine or amniotic infection during labour or delivery (confirm with trial site)
- People who experience heavy bleeding after giving birth
- People who need to be admitted to an intensive care unit (ICU) after delivery
- People who have a known allergy to medical-grade adhesive (the type of sticky material used to attach medical devices to skin)
- People who have skin sores, wounds, or other skin problems at the area where a continuous glucose monitor (a small sensor worn on the skin) would be placed
- People who have a non-ultrasound imaging scan — such as an X-ray, MRI, or CT scan — scheduled during the trial period
- People who are taking Metformin (a medication used to manage blood sugar)
- People who are taking steroid medications
- People who have taken Terbutaline (a medication sometimes used in pregnancy) within 4 hours of giving birth
- People who have cystic fibrosis
- People who have a condition called MODY (a rare inherited form of diabetes)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christina Han, MD, University of California, Los Angeles
Phone: 310-794-8893
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical Efficacy Associated with CGM use immediately postpartum as compared to the 2 hr Glucose tolerance test; Clinical Efficacy Associated with CGM use immediately postpartum as compared to the HbA1c test postpartum
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.